Stockscreener 앱 받기
1.47
0.00%
0.00
Ocugen Inc 주식(OCGN)의 최신 뉴스
Ocugen Eyes 3 Retinal Gene Therapy Filings as Late-Stage Pipeline Advances - Yahoo Finance
Ocugen at Piper Sandler ophthalmology day: gene therapy push advances By Investing.com - Investing.com Canada
Ocugen at Piper Sandler ophthalmology day: gene therapy push advances - Investing.com
Ocugen Inc. stock falls Thursday, underperforms market - MarketWatch
Ocugen’s Triple-Threat Pipeline: A $130M Cash Injection and a Summer of Make-or-Break Data - Ad-hoc-news.de
OCGN Stock Rallies On Wall Street Optimism For Clinical Pipeline: Retail Awaits New Data - Stocktwits
Ocugen stock stays tied to pipeline progress. Nasdaq listing keeps the US angle clear. - Ad-hoc-news.de
Ocugen Inc. stock falls Monday, underperforms market - MarketWatch
Why Did OCGN Stock Rise Today? - Stocktwits
Ocugen Inc. stock rises Thursday, outperforms market - MarketWatch
Ocugen Inc. stock falls Wednesday, underperforms market - MarketWatch
Ocugen to Participate in Upcoming July Industry Conferences - The Manila Times
Ocugen’s July retina conference talks include OCU410 phase 2 results - Stock Titan
Ocugen Inc. stock falls Tuesday, underperforms market - MarketWatch
Ocugen, Inc. pursues gene therapy innovation to address rare vision loss conditions - Traders Union
Ocugen Inc. stock rises Monday, outperforms market - MarketWatch
Ocugen, Inc.(NasdaqCM: OCGN) added to Russell Small Cap Comp Growth Benchmark - marketscreener.com
symbol__ Stock Quote Price and Forecast - CNN
Ocugen, Inc.(NasdaqCM: OCGN) added to Russell 2500 Growth Benchmark - marketscreener.com
Ocugen, Inc.(NasdaqCM: OCGN) added to Russell 2000 Index - marketscreener.com
OCGN Stock Grinds Higher As Traders Track Tight Range - StocksToTrade
Ocugen’s CFO Makes a Rare Open-Market Buy as Institutional Investors Pile In Ahead of Key Gene The - AD HOC NEWS
Ocugen, Inc.(NasdaqCM: OCGN) added to Russell 2000 Value Benchmark - marketscreener.com
Ocugen, Inc.(NasdaqCM: OCGN) added to Russell Microcap Value Benchmark Index - marketscreener.com
Ocugen, Inc.(NasdaqCM: OCGN) added to Russell 2000 Growth Benchmark - marketscreener.com
Ocugen, Inc.(NasdaqCM: OCGN) added to Russell 3000E Growth Benchmark - marketscreener.com
Ocugen, Inc.(NasdaqCM: OCGN) added to Russell 3000E Index - marketscreener.com
Ocugen, Inc.(NasdaqCM: OCGN) added to Russell Microcap Index - marketscreener.com
Ocugen, Inc.(NasdaqCM: OCGN) added to Russell Microcap Growth Benchmark Index - marketscreener.com
Ocugen, Inc.(NasdaqCM: OCGN) added to Russell 3000E Value Benchmark - marketscreener.com
Ocugen Inc. stock rises Friday, outperforms market - MarketWatch
OCGN Stock Holds Buy Rating As Analyst Sees Key Catalysts Ahead - StocksToTrade
Enterprise value to EBITDA forward of Ocugen, Inc. – NASDAQ:OCGN - TradingView
Has Ocugen's Recent Convertible Notes Offering Stabilized Its Financial Future - Kavout | AI
Price to book forward of Ocugen, Inc. – NASDAQ:OCGN - TradingView
Ocugen Inc Actuals & Estimates (NASDAQ:OCGN) - TradingView
Price to book forward of Ocugen Inc – SWB:2H51 - TradingView
Ocugen Inc (OCGN) Valuation: PE, PB & Fair Value Analysis - TradingKey
Enterprise value to revenue forward of Ocugen, Inc. – NASDAQ:OCGN - TradingView
Ocugen's gene-agnostic eye therapies could reshape late-stage care - MSN
Price to earnings forward of Ocugen, Inc. – NASDAQ:OCGN - TradingView
Price to sales forward of Ocugen Inc – SWB:2H51 - TradingView
Enterprise value to EBIT forward of Ocugen Inc – SWB:2H51 - TradingView
Price to earnings forward of Ocugen Inc – SWB:2H51 - TradingView
OCGN Forecast — Price Target — Prediction for 2027 - TradingView
Ocugen: Financing Risk Is Lower, But The Clinical Bet Still Has To Work - Seeking Alpha
Ocugen (OCGN) Stock Draws Fresh Price Target Split After Cautious Analyst View - Yahoo Finance
Ocugen Inc (OCGN) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Ocugen Inc. stock rises Tuesday, outperforms market - MarketWatch
OCGN Stock Holds Buy Rating As Analyst Trims Price Target - StocksToTrade
Ocugen completes OCU400 Phase 3 enrollment, shares trade in tight NASDAQ range - Ad-hoc-news.de
Ocugen StockFriday review and biotech sector context - AD HOC NEWS
Ocugen Inc. stock rises Wednesday, outperforms market - MarketWatch
Ocugen Inc (OCGN) Institutional Confidence - TradingKey
Ocugen Inc (OCGN) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Ocugen Inc (OCGN) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Ocugen Inc (OCGN) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Ocugen Inc (OCGN) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Ocugen Inc (OCGN) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Ocugen, Inc. leadership drives focus on innovative gene therapies at industry summit - Traders Union
Ocugen’s Shares Leap 32% Post Oppenheimer’s Positive Coverage - timothysykes.com
2.64%
자본화:
|
볼륨(24시간):